We are live on ! Find out more
GNMX

Aevi Genomic Medicine Inc
GNMX

Delisted

GNMX was delisted on the 3rd of February, 2020.

Back to rankings

2 hedge funds and large institutions have $0 invested in Aevi Genomic Medicine Inc in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

93% less funds holding

Funds holding: 28 → 2 (-26)

96% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 24

100% less capital invested

Capital invested by funds: $6.12M → $0 (-$6.12M)

Holders
2
Holders Change
-26
Holders Change %
-92.86%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PCMC
Private Capital Management (Colorado)
Colorado
+$2.92K

Top Sellers

Rank Fund Capital Flow
1
AMCA
Arthur M. Cohen & Associates
Illinois
-$5.33M
2
Renaissance Technologies
Renaissance Technologies
New York
-$382K
3
Vanguard Group
Vanguard Group
Pennsylvania
-$156K
4
BlackRock
BlackRock
New York
-$100K
5
UBS Group
UBS Group
Switzerland
-$29K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
– -$382K -2,615,632 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$156K -1,066,587 Closed
BlackRock
3
BlackRock
New York
– -$100K -683,551 Closed
UBS Group
4
UBS Group
Switzerland
– -$29K -198,732 Closed
JC
5
JBF Capital
Colorado
– -$27K -187,945 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$24K -167,547 Closed
California Public Employees Retirement System
7
California Public Employees Retirement System
California
– -$7K -51,000 Closed
Northern Trust
8
Northern Trust
Illinois
– -$7K -50,541 Closed
AMCA
9
Arthur M. Cohen & Associates
Illinois
– -$5.33M -36,500 Closed
VAM
10
Verity Asset Management
North Carolina
– -$4K -30,500 Closed
Bank of America
11
Bank of America
North Carolina
– -$4K -26,739 Closed
State Street
12
State Street
Massachusetts
– -$3K -17,213 Closed
OIA
13
OneDigital Investment Advisors
Kansas
– -$2K -15,555 Closed
Wells Fargo
14
Wells Fargo
California
– -$2K -15,384 Closed
DAS
15
Dynamic Advisor Solutions
Arizona
– -$2K -12,000 Closed
MWP
16
MYCIO Wealth Partners
Pennsylvania
– -$1K -10,000 Closed
WQ
17
Wealth Quarterback
New Jersey
– -$10 -70 Closed
BNP Paribas Financial Markets
18
BNP Paribas Financial Markets
France
– -$1 -4 Closed
PCMC
19
Private Capital Management (Colorado)
Colorado
– +$2.92K +15,306 New

GNMX Hedge Fund Activity: Q1 2020 in Review

2 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Aevi Genomic Medicine Inc (GNMX) for Q1 2020, worth a combined $0 — down 100% from $6.12M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of GNMX and 1 opened new positions — a net loss of 23 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Private Capital Management (Colorado), opening a new position worth an estimated $2.92K. The largest seller was Arthur M. Cohen & Associates, exiting entirely with an estimated $5.33M sold.

  • 2 institutional investors held Aevi Genomic Medicine Inc (GNMX) as of Q1 2020, down from 28 in Q4 2019.
  • Funds reported $0 of Aevi Genomic Medicine Inc stock for Q1 2020, down 100% quarter-over-quarter.
  • 1 fund opened new Aevi Genomic Medicine Inc positions in Q1 2020 and 24 closed out, a net change of -23 holders.
  • The largest Aevi Genomic Medicine Inc buyer in Q1 2020 was Private Capital Management (Colorado), an estimated $2.92K added.
  • The largest Aevi Genomic Medicine Inc seller in Q1 2020 was Arthur M. Cohen & Associates, an estimated $5.33M sold.

Based on aggregated 13F filings for Q1 2020.